Retatrutide
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Eli Lilly · Phase 2 · Completed · Enrollment 146
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.